Finance

Lists
002755:SHE
Beijing Aosaikang Pharmaceutical Co Ltd
CNÂ¥12,52
-1,65%
(-0,21) 1D
14 Okt., 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002755...
Open
CNÂ¥12,73
High
CNÂ¥12,86
Low
CNÂ¥12,46
Mkt. cap
11,82 mjd
Avg. vol.
14,34 m
Volume
10,39 m
Dividend
0,96%
Quarterly dividend
CNÂ¥0,03
Ex-dividend date
18 Jun. 2026
P/E ratio
58,91
52-wk high
CNÂ¥20,75
52-wk low
CNÂ¥11,02
EPS
CNÂ¥0,21
Shares outstanding
928,16 m
No. of employees
799
Open
CNÂ¥12,73
High
CNÂ¥12,86
Low
CNÂ¥12,46
Mkt. cap
11,82 mjd
Avg. vol.
14,34 m
Volume
10,39 m
Dividend
0,96%
Quarterly dividend
CNÂ¥0,03
Ex-dividend date
18 Jun. 2026
P/E ratio
58,91
52-wk high
CNÂ¥20,75
52-wk low
CNÂ¥11,02
EPS
CNÂ¥0,21
Shares outstanding
928,16 m
No. of employees
799
News stories
From web sources and news partners
About Beijing Aosaikang Pharmaceutical Co Ltd
CEO-
Employees799
Founded24 Des. 1996
Headquarters-
SectorPharmaceutical industry
Websiteask-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
426,48 m
345,13 m
481,78 m
389,27 m
Cost of goods sold
104,64 m
63,62 m
76,60 m
80,08 m
Cost of revenue
104,64 m
63,62 m
76,60 m
80,08 m
Research and development expenses
24,80 m
43,39 m
26,24 m
120,77 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,93 m
211,23 m
271,28 m
158,63 m
Operating expense
240,44 m
295,08 m
300,50 m
286,52 m
Total operating expenses
345,08 m
358,70 m
377,10 m
366,59 m
Operating income
81,40 m
-13,57 m
104,68 m
22,67 m
Other non operating income
936,04 k
1,76 m
273,08 k
-1,29 m
EBT including unusual items
64,12 m
38,49 m
112,80 m
34,94 m
EBT excluding unusual items
80,66 m
-7,60 m
108,10 m
27,24 m
Income tax expense
3,90 m
32,42 m
8,92 m
5,98 m
Effective tax rate
6,08%
84,22%
7,91%
17,12%
Other operating expenses
-29,70 m
40,68 m
5,15 m
4,16 m
Net income
63,33 m
13,29 m
84,47 m
36,16 m
Net profit margin
14,85%
3,85%
17,53%
9,29%
Earnings per share
-
-
-
-
Interest and investment income
-
3,63 m
4,33 m
6,42 m
Interest expense
-1,05 m
-99,07 k
-1,18 m
-
Net interest expenses
-1,05 m
3,53 m
3,15 m
6,42 m
Depreciation and amortization charges
-
-
-
-
EBITDA
100,22 m
17,89 m
136,14 m
54,31 m
Gain or loss from assets sale
-
27,23 k
-
383,90 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme